Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide
Rose, W.C.; Trader, M.W.; Laster, W.R.; Schabel, F.M.
Cancer Treatment Reports 62(9): 1337-1349
1978
ISSN/ISBN: 0361-5960 PMID: 688277 Document Number: 129385
Document emailed within 1 workday
Related Documents
Bodey, G.P.; Rodriguez, V.; Hart, J.; Freireich, E.J. 1970: Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271) Cancer ChemoTherapy Reports 54(4): 255-262Gordon, R.O.; Santanelli, J.P.; Wade, M.E. 1971: The production of tolerance to human erythrocytes in the rat with cytosine arabinoside or cyclophosphamide. II. Previously immunized animals Journal of Immunology 106(3): 865-867
Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Yang, G.S.; Wang, C.; Minden, M.D.; McCulloch, E.A. 1994: Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity Leukemia 8(12): 2052-2059
Whitecar, J.P.; Bodey, G.P.; Freireich, E.J.; McCredie, K.B.; Hart, J.S. 1972: Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults Cancer ChemoTherapy Reports 56(4): 543-550
Surkova, N.I.; Malashenko, A.M. 1975: Cytogenetic effect of mitomycin C and cytosine arabinoside on mice of different genotypes Genetika 11(9): 38-45
Liss, R.H.; Neil, G.L. 1975: Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in mice Cancer ChemoTherapy Reports 59(3): 501-513
Grant, S.; Traylor, R.; Bhalla, K.; Mccrady, C.; Pettit, G.R. 1992: Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells Leukemia 6(5): 432-439
Nagatoshi, Y.; Okamura, J.; Ikuno, Y.; Akamatsu, M.; Tasaka, H. 1997: Therapeutic trial of intensified conditioning regimen with high-dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children International Journal of Hematology 65(3): 269-275
Fukuhara, T.; Miyake, T.; Maekawa, I.; Kurosawa, M.; Suzuki, S.; Noto, S.; Mori, A.; Chiba, K.; Toyoshima, T.; Hirano, T.; Morioka, M.; Tsutsumi, Y.; Okabe, M.; Kakinoki, Y. 2000: Treatment with low-dose cytosine arabinoside followed by administration of macrophage colony-stimulating factor prolongs the survival of patients with RAEB, RAEB-T, or leukemic phase myelodysplastic syndrome: a pilot study International Journal of Hematology 71(4): 366-371
Jastrzebski, Z.; Danysz, A.; Czyzewska-Szafran, H.; Czarnomska, A. 1988: The effect of sodium-2-mercaptoethane-sulphonate, N-acetylcysteine and cysteine on the uptake of cytosine arabinoside by normal and neoplastic thymus cells of mice Archivum Immunologiae et Therapiae Experimentalis 36(3): 335-343
Frindel, E.; Masse, A.; Pradelles, P.; Volkov, L.; Rigaud, M. 1992: Correlation of endogenous acetyl-ser-asp-lys-pro plasma levels in mice and the kinetics of pluripotent hemopoietic stem cells entry into the cycle after cytosine arabinoside treatment: fundamental and clinical aspects Leukemia 6(6): 599-601
Peterlejtner, E. 1978: Ophthalmic zoster treated with cytosine arabinoside Klinika Oczna 48(2): 71-72
Kufe, D.W.; Spriggs, D.R. 1985: Biochemical and cellular pharmacology of cytosine arabinoside Seminars in Oncology 12(2 Suppl 3: 34-48
Hanka, L.J.; Kuentzel, S.L.; Neil, G.L. 1970: Improved microbiological assay for cytosine arabinoside (NSC-63878) Cancer ChemoTherapy Reports 54(6): 393-397
Pytel-Dabrowska, T.; Balcar-Boroń, A.; Nowaczyk-Michalak, A. 1980: Cytosine arabinoside in the treatment of herpes simplex and chickenpox Wiadomosci Lekarskie 33(12): 957-959
Gallo, J.H.; Rozenberg, M.C. 1986: Response of refractory anemia to low-dose cytosine arabinoside Australian and New Zealand Journal of Medicine 16(2): 231-233
Tatsumi, N.; Masaoka, T.; Ueda, Y.; Senda, N. 1970: Treatment of leukemia with cytosine arabinoside--on the intensification of remission Gan no Rinsho. Japan Journal of Cancer Clinics 16(7): 706-712
Derulska, D.; Rokicka-Milewska, R. 1975: Cytosine arabinoside in the treatment of acute leukemia in children Pediatria Polska 50(6): 723-728
Madon, E.; Baroncelli, P.G.; Sacerdote, A.; Roberi, P.L. 1971: Treatment of acute leukemias in the infancy with cytosine arabinoside Minerva Pediatrica 23(26): 1125-1129